6:03 PM
 | 
Apr 20, 2009
 |  BC Extra  |  Company News

Discovery Labs receives Surfaxin complete response

Discovery Laboratories Inc. (NASDAQ:DSCO) fell $0.89 (49%) to $0.91 on Monday after announcing that on Friday it received a complete response from FDA for an NDA for Surfaxin lucinactant to prevent respiratory...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >